User login
Squamous Cell Carcinoma of the Lip Associated With Adalimumab Therapy for Ankylosing Spondylitis: A Case Report and Review of TNF-α Inhibitors and Cutaneous Carcinoma Risk
Article Type
Changed
Thu, 12/15/2022 - 15:09
Display Headline
Squamous Cell Carcinoma of the Lip Associated With Adalimumab Therapy for Ankylosing Spondylitis: A Case Report and Review of TNF-α Inhibitors and Cutaneous Carcinoma Risk
Article PDF
Issue
Cutis - 92(1)
Topics
Page Number
35-39
Legacy Keywords
TNF-alpha inhibitors and skin cancer, adverse effects of anti-TNF-alpha agents, nonmelanoma skin cancers, risks of anti-TNF-alpha therapy, anti-TNF-alpha therapy and increased risk for metastasis, tumor necrosis factor
Sections
Article PDF
Article PDF
Issue
Cutis - 92(1)
Issue
Cutis - 92(1)
Page Number
35-39
Page Number
35-39
Topics
Article Type
Display Headline
Squamous Cell Carcinoma of the Lip Associated With Adalimumab Therapy for Ankylosing Spondylitis: A Case Report and Review of TNF-α Inhibitors and Cutaneous Carcinoma Risk
Display Headline
Squamous Cell Carcinoma of the Lip Associated With Adalimumab Therapy for Ankylosing Spondylitis: A Case Report and Review of TNF-α Inhibitors and Cutaneous Carcinoma Risk
Legacy Keywords
TNF-alpha inhibitors and skin cancer, adverse effects of anti-TNF-alpha agents, nonmelanoma skin cancers, risks of anti-TNF-alpha therapy, anti-TNF-alpha therapy and increased risk for metastasis, tumor necrosis factor
Legacy Keywords
TNF-alpha inhibitors and skin cancer, adverse effects of anti-TNF-alpha agents, nonmelanoma skin cancers, risks of anti-TNF-alpha therapy, anti-TNF-alpha therapy and increased risk for metastasis, tumor necrosis factor
Sections
Disallow All Ads
Alternative CME
Article PDF Media
Document